<< Back To Home

--- Reduced Price on Rotavirus Vaccines

Sunday, 14th of October 2012 Print
  • REDUCED PRICE ON ROTAVIRUS VACCINES

From conclusion; full text is at

http://www.who.int/bulletin/volumes/90/7/11-094656/en/index.html

The two major pharmaceutical compa­nies that manufacture rotavirus vaccines have recently offered to sell these vac­cines to the world’s poorest countries at greatly reduced prices. This is eloquent proof of the industry’s commitment to facilitating access to life-saving vac­cines. However, even at these lowered prices rotavirus vaccines would still be substantially more expensive than traditional childhood vaccines and the introduction and sustainment of a ro­tavirus vaccination programme would still be unaffordable for low-income countries. Thus, vaccine manufacturers need to be pressured to further reduce the price of their vaccines, and new sustainable financing opportunities for immunization programmes in low-income countries need to be identified. These pursuits should rank high on the agendas of international health and development organizations.

By reducing deaths from rotavi­rus-associated diarrhoea, universal access to rotavirus vaccines could greatly contribute to the attainment of the United Nations’ Millennium Development Goal of reducing child mortality. The international public health community should make every effort to ensure universal access to rotavirus vaccines.

 

 

41050902